GlassScriptPhysician profile
Karen A Voegtle
NPI 1104823251
$1,844.81
in general payments reported to CMS, 2019-2025
29 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $205 · 2021: $221 · 2022: $362 · 2023: $202 · 2024: $316 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $457.60 | 2019-2024 | Ubrelvy, Liletta |
| Astellas Pharma US INC | $207.38 | 2023-2025 | Veozah |
| Allergan, INC. | $193.76 | 2019 | |
| Pfizer INC. | $130.17 | 2019-2024 | |
| Exeltis, USA INC. | $102.42 | 2022-2025 | Slynd |
| Sage Therapeutics, LLC | $96.92 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $79.69 | 2021-2023 | Twirla |
| Organon LLC | $63.92 | 2022-2024 | |
| Amag Pharmaceuticals, INC. | $55.24 | 2019-2020 | |
| Daiichi Sankyo INC. | $48.43 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $38.54 | 2019-2020 | |
| Avion Pharmaceuticals | $37.03 | 2022 | |
| Hologic Sales and Service, LLC | $35.84 | 2020-2021 | |
| Myovant Sciences INC. | $31.92 | 2021-2022 | |
| Amgen INC. | $27.09 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $23.74 | 2025 | Fanapt |
| Sumitomo Pharma America, INC. | $23.53 | 2023 | Myfembree |
| Lilly USA, LLC | $23.18 | 2024 | Zepbound |
| Novo Nordisk INC | $21.90 | 2024 | Wegovy |
| Exact Sciences Corporation | $18.34 | 2025 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $16.63 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.91 | 2021 | |
| Evofem Biosciences, INC. | $15.90 | 2021 | |
| Minerva Surgical, INC | $15.38 | 2023 | |
| Duchesnay USA Incorporated | $14.52 | 2019 | |
| Glaxosmithkline, LLC. | $13.15 | 2022 | |
| Therapeuticsmd, INC. | $12.93 | 2019 | |
| Meditrina | $12.13 | 2023 | |
| Lupin INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Voegtle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.